Perrigo Company PLC (NYSE:PRGO)
10.795 USD
+0.095 0.888%Sponsored Reports
| Previous Close (in USD) | 10.7 |
|---|---|
| Change | +0.095 0.888% |
| 52 W H/L (in USD) | 39.614/26.569 |
| EBITDA (in USD) | 654.2M |
| PE Ratio | 396.25 |
| Volume | 906086 |
| Diluted Eps TTM | 0.08 |
| Total Assets (in USD) | 11017.3M |
|---|---|
| Total Liabilities (in USD) | 6175.2M |
| Revenue TTM (in USD) | 4654M |
| Cash (in USD) | 600.7M |
| Market Cap (in USD) | 4,295.540 M |
| Revenue Per Share TTM | 34.449 |
| Gross Profit TTM (in USD) | 1455.4M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Perrigo Company PLC
Employees: 8900
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Murray S. Kessler | CEO, Pres & Director | 1960 |
| 2. | Mr. Svend Andersen | Exec. VP & Pres of Consumer Self-Care International | 1962 |
| 3. | Mr. James E. Dillard III | Exec. VP & Pres of Consumer Self-Care Americas | 1964 |
| 4. | Mr. Eduardo Guarita Bezerra | Exec. VP & CFO | 1975 |
| 5. | Mr. Ronald C. Janish | Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain | 1966 |
| 6. | Mr. Shannon Hukill | Sr. Director of Technical Operations | NA |
| 7. | Mr. Thomas M. Farrington | Chief Information Officer & Exec. VP | 1957 |
| 8. | Ms. Alison Ives | Exec. VP & Chief Scientific Officer | NA |
| 9. | Mr. Bradley Joseph | VP of Global Investor Relations & Corp. Communications | NA |
| 10. | Ms. Kyle L. Hanson | Exec. VP, Gen. Counsel & Corp. Sec. | 1965 |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
-1.370 1.714% | 80.245 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
-0.080 0.260% | 30.67 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
0.000 0.000% | 155.21 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
GALDY
GALDERMA GROUP AG |
-0.756 1.742% | 43.62 | 74.210 | 41.667 | 8.636 | 5.553 | 9.151 | 42.220 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -139.1M | 258.7M | -149.4M | 171M | 290.6M |
| Minority Interest | - | - | - | 0.3M | 0.1M |
| Net Income | -130.9M | -130.9M | -162.6M | 146.1M | 131M |
| Selling General Administrative | 512.3M | 482M | 496M | 503M | 435.9M |
| Gross Profit | 1455.4M | 1416.2M | 1815.2M | 1773.3M | 1831.5M |
| Reconciled Depreciation | 338.6M | 312.2M | 384.8M | 396.5M | 423.6M |
| Ebit | 172.8M | 573.7M | 932.4M | 604.5M | 539.1M |
| Ebitda | 511.4M | 885.9M | 1317.2M | 1001M | 962.7M |
| Depreciation And Amortization | 338.6M | 312.2M | 384.8M | 396.5M | 423.6M |
| Operating Income | 172.8M | 573.7M | 932.4M | 604.5M | 236.5M |
| Other Operating Expenses | 4330.2M | 3538.3M | 4597.6M | 4421.8M | 4249.8M |
| Interest Expense | 156M | 125M | 125M | 121.7M | 128M |
| Tax Provision | -8.2M | 389.6M | 13.2M | 24.9M | 159.6M |
| Interest Income | - | - | 131.2M | 96.3M | 120.4M |
| Net Interest Income | -156M | -125M | -131.2M | -121.7M | -128M |
| Income Tax Expense | -8.2M | 389.6M | 13.2M | 24.9M | 159.6M |
| Total Revenue | 4451.6M | 4138.7M | 5063.3M | 4837.4M | 4731.7M |
| Total Operating Expenses | 1334M | 815.8M | 1349.5M | 1357.7M | 1349.6M |
| Cost Of Revenue | 2996.2M | 2722.5M | 3248.1M | 3064.1M | 2900.2M |
| Total Other Income Expense Net | -311.9M | -315M | -1081.8M | -433.5M | -63.3M |
| Net Income From Continuing Ops | -130.9M | -130.9M | -162.6M | 146.1M | 131M |
| Net Income Applicable To Common Shares | -140.6M | -68.9M | -162.6M | 146.1M | 131M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Total Assets | 11017.3M | 10425.7M | 11488.4M | 11301.4M | 10983.4M |
| Intangible Assets | 3230.2M | 2146.1M | 2974.3M | 2921.2M | 2858.9M |
| Other Current Assets | 271.8M | 321.9M | 237.6M | 192.1M | 400M |
| Total Liab | 6175.2M | 5274M | 5833.3M | 5497.3M | 5315.3M |
| Total Stockholder Equity | 4842.1M | 5151.7M | 5655.1M | 5803.8M | 5668M |
| Other Current Liab | 533M | 32.9M | 800.4M | 812.2M | 872.3M |
| Common Stock | 6936.7M | 7043.2M | 7118.2M | 7359.9M | 7421.7M |
| Capital Stock | 6936.7M | 7043.2M | 7118.2M | 7359.9M | 7421.7M |
| Retained Earnings | -2067.6M | -1927M | -1858.1M | -1695.5M | -1838.3M |
| Good Will | 3549M | 3004.7M | 3783.9M | 4185.5M | 4029.1M |
| Other Assets | 240.2M | 384M | 3576M | 357.4M | 344.6M |
| Cash | 600.7M | 1864.9M | 641.5M | 354.3M | 551.1M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 1113.6M | 1587.9M | 1382M | 1335.8M | 1537.4M |
| Current Deferred Revenue | 7.1M | 540M | 44M | - | - |
| Net Debt | 3505.9M | 1655.6M | 2924.6M | 3014.9M | 2691.3M |
| Short Term Debt | 36.2M | 603.8M | 37.8M | 3.4M | 190.2M |
| Short Long Term Debt | 36.2M | 603.8M | 37.8M | 3.4M | 190.2M |
| Short Long Term Debt Total | 4106.6M | 3520.5M | 3566.1M | 3369.2M | 3242.4M |
| Other Stockholder Equity | 6936.7M | 7043M | 395M | 0.4M | -0.4M |
| Property Plant Equipment | 1165.4M | 1031M | 996M | 902.8M | 829.1M |
| Total Current Assets | 2719.9M | 3859.9M | 3133.5M | 2756.9M | 2902.2M |
| Long Term Investments | - | - | - | 20.1M | 19.5M |
| Short Term Investments | - | - | - | 6.6M | 9.4M |
| Net Receivables | 697.1M | 652.9M | 1054.2M | 1243.2M | 1073.1M |
| Long Term Debt | 4070.4M | 2916.7M | 3528.3M | 3365.8M | 3052.2M |
| Inventory | 1150.3M | 1020.2M | 1200.2M | 967.3M | 878M |
| Accounts Payable | 537.3M | 411.2M | 543.8M | 520.2M | 474.9M |
| Accumulated Other Comprehensive Income | -27M | 35.5M | 395M | 139.4M | 84.6M |
| Non Currrent Assets Other | 367.7M | 377.5M | 370.5M | 399.7M | 362.9M |
| Non Current Assets Total | 8297.4M | 6565.8M | 8354.9M | 8544.5M | 8081.2M |
| Capital Lease Obligations | 189.5M | 173.3M | - | - | - |
| Long Term Debt Total | - | 2916.7M | 3528.3M | 3365.8M | 3052.2M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -1958.6M | 1275.8M | -15M | -596.1M | -7.5M |
| Total Cashflows From Investing Activities | -1958.6M | 1275.8M | -187.8M | -596.1M | -126.8M |
| Total Cash From Financing Activities | 421.6M | -178.7M | -181.1M | 1.8M | -571.9M |
| Net Income | -140.6M | -68.9M | -162.6M | 146.1M | 131M |
| Change In Cash | -1264.2M | 1233.4M | 287.2M | -196.8M | -127.6M |
| Begin Period Cash Flow | 1864.9M | 631.5M | 354.3M | 551.1M | 678.7M |
| End Period Cash Flow | 600.7M | 1864.9M | 641.5M | 354.3M | 551.1M |
| Total Cash From Operating Activities | 307.3M | 156.3M | 636.2M | 387.8M | 593M |
| Depreciation | 338.6M | 312.2M | 384.8M | 396.5M | 423.6M |
| Other Cashflows From Investing Activities | 61.7M | 2.8M | -2.4M | -309.3M | -16.7M |
| Dividends Paid | 142.4M | 129.6M | 123.9M | 112.4M | 104.9M |
| Change To Inventory | -76.7M | -2.4M | -170.6M | -67M | -98.6M |
| Sale Purchase Of Stock | 0M | 0M | -164.2M | 600.5M | -400M |
| Other Cashflows From Financing Activities | 1522.9M | -49.1M | -23.9M | -11.2M | 418.6M |
| Capital Expenditures | 96.4M | 152.1M | 170.4M | 137.7M | 102.6M |
| Change In Working Capital | 20M | -295.4M | -69.2M | -313.5M | -19.4M |
| Other Non Cash Items | 84.9M | 138.9M | 479.2M | 150.4M | 38M |
| Free Cash Flow | 210.9M | 4.2M | 465.8M | 250.1M | 490.4M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 4246493 |
| 2. | iShares Core S&P Mid-Cap ETF | 2 years ago | 4164032 |
| 3. | Vanguard Small Cap Index | 2 years ago | 3508605 |
| 4. | Vanguard Small Cap Value Index Inv | 2 years ago | 2438325 |
| 5. | Touchstone Mid Cap Y | 2 years ago | 2107546 |
| 6. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 1955643 |
| 7. | DFA US Small Cap Value I | 2 years ago | 1759613 |
| 8. | Vanguard Selected Value Inv | 2 years ago | 1272941 |
| 9. | SPDR® S&P MIDCAP 400 ETF Trust | 2 years ago | 1084221 |
| 10. | ProShares S&P MidCap 400 Dividend Arst | 2 years ago | 1014578 |
| 11. | Transamerica Mid Cap Value Opps I3 | 2 years ago | 965700 |
| 12. | American Beacon Small Cp Val R5 | 2 years ago | 953472 |
| 13. | iShares S&P Mid-Cap 400 Value ETF | 2 years ago | 832220 |
| 14. | Vanguard Dividend Appreciation ETF | 2 years ago | 777961 |
| 15. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 763092 |
| 16. | Fidelity® Extended Market Index | 2 years ago | 734540 |
| 17. | Davenport Small Cap Focus | 2 years ago | 728469 |
| 18. | Dimensional US Targeted Value ETF | 2 years ago | 726080 |
| 19. | Diamond Hill Long-Short Inv | 2 years ago | 717434 |
| 20. | DFA US Core Equity 2 I | 2 years ago | 656243 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Group Inc | 2 years ago | 14902987 |
| 2. | BlackRock Inc | 2 years ago | 12906961 |
| 3. | Dimensional Fund Advisors, Inc. | 2 years ago | 6493279 |
| 4. | Wolf Hill Capital Management, LP | 2 years ago | 6415580 |
| 5. | State Street Corporation | 2 years ago | 4368315 |
| 6. | Cooke & Bieler LP | 2 years ago | 3509261 |
| 7. | Coho Partners Ltd | 2 years ago | 3202169 |
| 8. | Davenport & Company LLC | 2 years ago | 3170926 |
| 9. | London Company of Virginia | 2 years ago | 2818468 |
| 10. | DePrince Race & Zollo Inc | 2 years ago | 2692619 |
| 11. | Thompson, Siegel & Walmsley LLC | 2 years ago | 2303594 |
| 12. | Copeland Capital Management, LLC | 2 years ago | 2051202 |
| 13. | Geode Capital Management, LLC | 2 years ago | 2020676 |
| 14. | Sessa Capital IM LP | 2 years ago | 1927008 |
| 15. | Perpetual Ltd | 2 years ago | 1876506 |
| 16. | Cooper Creek Partners Management LLC | 2 years ago | 1872508 |
| 17. | Camber Capital Management LLC | 2 years ago | 1850000 |
| 18. | Holocene Advisors, LP | 2 years ago | 1789033 |
| 19. | Northern Trust Corp | 2 years ago | 1582731 |
| 20. | Alyeska Investment Group, L.P. | 2 years ago | 1544405 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).